文献速递免疫规划

融合PspA与PotD的蛋白嵌合体对小鼠侵袭性肺炎链球菌感染具有保护作用并减少鼻咽部定植

A protein chimera including PspA in fusion with PotD is protective against invasive pneumococcal infection and reduces nasopharyngeal colonization in mice.
PubMed 文献 · Vaccine · 2017-08-14

为应对现有多糖疫苗对肺炎链球菌保护不足的问题,本研究构建了PspA与PotD融合的嵌合蛋白,并在小鼠模型中评估其保护效果。结果显示该融合蛋白保留了双亲本蛋白的保护特性,可抵御全身感染并减少鼻咽部定植,且能诱导针对多种血清型菌株的抗体、增强调理吞噬并促进脾细胞分泌IL-17。

要点

  • rPspA-PotD融合蛋白可针对全身感染提供保护并减少鼻咽部定植。
  • 该融合蛋白未能提升单独PspA对侵袭性疾病的保护应答。
  • 融合蛋白诱导的抗体对多种血清型菌株结合能力增强并增强调理吞噬。

核心结论

  • 基于表面抗原的嵌合蛋白是抗击肺炎链球菌感染的有效策略。

研究设计与样本

  • 本研究为小鼠模型研究,评估PspA与PotD融合嵌合蛋白的保护效果。

主要发现

  • rPspA-PotD融合蛋白保留了PspA和PotD两种亲本蛋白的保护特性,可抵御全身感染并减少鼻咽部定植。
  • 该融合蛋白未能改善单独PspA对侵袭性疾病激发的应答。
  • 纳入PotD可减少定植,而使用PspA皮下免疫从未观察到该效果。
  • 融合蛋白诱导的抗体对多种血清型和遗传背景的肺炎链球菌菌株结合能力增强,并增强调理吞噬作用及脾细胞分泌IL-17。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Despite the success of the available polysaccharide-based vaccines against Streptococcus pneumoniae in preventing invasive diseases, this bacterium remains a major cause of death in many parts of the world. New vaccine strategies are needed in order to increase protection. Thus, the utilization of fusion proteins is being investigated as an alternative to the current formulations. In the present work, we demonstrate that a chimeric protein, composed of PspA and PotD in fusion is able to maintain the protective characteristics of both parental proteins, providing protection against systemic infection while reducing nasal colonization. The hybrid was not able to improve the response against invasive disease elicited by PspA alone, but the inclusion of PotD was able to reduce colonization, an effect never observed using subcutaneous immunization with PspA. The mechanisms underlying the protective efficacy of the rPspA-PotD hybrid protein were investigated, revealing the production of antibodies with an increased binding capacity to pneumococcal strains of diverse serotypes and genetic backgrounds, enhanced opsonophagocytosis, and secretion of IL-17 by splenocytes. These findings reinforce the use of chimeric proteins based on surface antigens as an effective strategy against pneumococcal infections.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Converso TR, Goulart C, Darrieux M, et al. A protein chimera including PspA in fusion with PotD is protective against invasive pneumococcal infection and reduces nasopharyngeal colonization in mice. Vaccine. 2017. PMID: 28818567. doi:10.1016/j.vaccine.2017.08.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。